We are pleased to announce that our original research article on the capability of individual-centric spheroid model to detect immune-mediated idiosyncratic DILI at therapeutic doses has just been published in Frontiers in Pharmacology, section Predictive Toxicology.
« Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone”
Front. Pharmacol., 10 April 2024
Sec. Predictive Toxicology
Volume 15 – 2024 | https://doi.org/10.3389/fphar.2024.1378371
Our technology opens perspectives for better selection of lead compounds de-risking failures due to liver injury.
